Liquidia Corp (LQDA)
11.05
+0.22
(+2.03%)
USD |
NASDAQ |
Nov 08, 16:00
11.05
0.00 (0.00%)
After-Hours: 20:00
Liquidia Revenue (Annual): 17.49M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 17.49M |
December 31, 2022 | 15.94M |
December 31, 2021 | 12.85M |
December 31, 2020 | 0.7396M |
Date | Value |
---|---|
December 31, 2019 | 8.072M |
December 31, 2018 | 2.707M |
December 31, 2017 | 7.258M |
December 31, 2016 | 13.22M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.7396M
Minimum
2020
17.49M
Maximum
2023
11.02M
Average
12.85M
Median
2021
Revenue (Annual) Benchmarks
United Therapeutics Corp | 2.328B |
Arcturus Therapeutics Holdings Inc | 157.75M |
Paragon 28 Inc | 216.39M |
Tonix Pharmaceuticals Holding Corp | 7.768M |
AIM ImmunoTech Inc | 0.202M |